Physician profile
Allison Wright
NPI 1063943785
$334.28
in general payments reported to CMS, 2019-2025
10 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $57.26 · 2024: $74.91 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $317 · Education: $17.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $316.97 |
| Education | $17.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $91.67 | 2023-2025 | Trelegy Ellipta, Arexvy |
| Insmed, INC. | $60.06 | 2025 | Arikayce |
| Amgen INC. | $36.82 | 2025 | Tavneos, Tezspire |
| Astrazeneca Pharmaceuticals Lp | $29.53 | 2025 | Fasenra |
| Inspire Medical Systems, INC. | $22.82 | 2025 | Inspire |
| Merck Sharp & Dohme LLC | $21.81 | 2025 | Keytruda |
| Tactile Systems Technology INC | $19.69 | 2024 | Flexitouch Plus, Entre Plus |
| Zoll Respicardia, INC. | $19.25 | 2024 | Remede System |
| Livanova USA, INC. | $17.31 | 2023 | Lifesparc |
| Grifols USA, LLC | $15.32 | 2024 | Prolastin-C Liquid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.